| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |